What are HealthEquity's total assets?

HealthEquity (HQY) holds $3.3B in total assets, down 3.2% year over year.

How much debt does HealthEquity have?

HealthEquity carries $984.7M in total debt against $2.0B of shareholders' equity, a debt-to-equity ratio of 0.48.

How much cash does HealthEquity have?

HealthEquity holds $265.4M in cash and equivalents.

Can HealthEquity cover its short-term obligations?

Its current ratio is 3.44 — current assets exceed current liabilities.

Where does HealthEquity's balance sheet data come from?

Every line is extracted from HealthEquity's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.

HealthEquity HQY Balance Sheet Statement

Income Statement Balance Sheet Cash Flow Ratios Segments

Quarterly Annual TTM

YoY

Simplified Detailed

	FY'26	FY'25	FY'24	FY'23
Cash and cash equivalents	$318.93M+7.8%	$295.95M-26.7%	$403.98M+58.9%	$254.27M+12.8%
Accounts receivable, net	$123.7M+4.8%	$118.01M+12.5%	$104.89M+8.3%	$96.84M+10.8%
Prepaid expenses and other current assets	$69.66M+9.2%	$63.8M+104%	$31.2M-1.9%	$31.79M-17.4%
Total current assets	$512.28M+7.2%	$477.75M-14.3%	$557.44M+45.6%	$382.89M+9.0%
Property and equipment, net	$3.18M-1.9%	$3.24M-46.1%	$6.01M-53.2%	$12.86M-45.0%
Accumulated depreciation	$37.32M+1.8%	$36.65M-10.6%	$41.02M-1.9%	$41.82M+17.5%
Operating lease right-of-use assets	$36.31M-15.9%	$43.19M-10.7%	$48.38M-14.3%	$56.46M-11.2%
Goodwill	$1.65B0.0%	$1.65B0.0%	$1.65B0.0%	$1.65B+0.1%
Intangible assets, net	$1.1B-8.9%	$1.2B+44.1%	$835.95M-10.7%	$936.36M-3.8%
Other non-current assets	$83.25M+16.3%	$71.57M+5.5%	$67.87M+30.1%	$52.18M+4.8%
Total assets	$3.38B-2.0%	$3.45B+9.0%	$3.16B+2.4%	$3.09B-0.6%
Accrued expenses	$60.39M-12.9%	$69.33M+39.8%	$49.61M+8.2%	$45.84M-2.8%
Deferred revenue	$6.7M-60.8%	$17.1M+176%	$6.2M-25.3%	$8.3M-21.0%
Current portion of long-term debt	$0—	$0—	$0-100%	$17.5M+100%
Operating lease liabilities, current	$9.91M-0.9%	$10M+6.3%	$9.4M-7.4%	$10.16M-16.5%
Income taxes payable	——	——	——	——
Total current liabilities	$156.85M+0.3%	$156.32M+33.5%	$117.09M-10.7%	$131.06M-14.4%
Long-term debt	$957.38M-9.4%	$1.06B+20.7%	$874.97M-3.6%	$907.84M-1.5%
Operating lease liabilities, non-current	$34.19M-19.0%	$42.22M-13.4%	$48.77M-17.3%	$58.99M-9.6%
Other non-current liabilities	$31.01M+35.0%	$22.96M+19.2%	$19.27M+51.6%	$12.71M-10.4%
Total noncurrent liabilities	$1.12B-5.2%	$1.18B+16.4%	$1.01B-4.8%	$1.06B-3.6%
Total liabilities	$1.27B-4.5%	$1.33B+18.1%	$1.13B-5.4%	$1.19B-4.9%
Preferred stock	$0—	$0—	$0—	$0—
Common stock	900M+9,999,900%	9K0.0%	9K+12.5%	8K0.0%
Additional paid-in capital	$1.92B+0.6%	$1.91B+4.2%	$1.83B+4.8%	$1.75B+4.1%
Retained earnings	$195.91M-6.4%	$209.27M+1.8%	$205.63M+37.2%	$149.92M-14.8%
Accumulated other comprehensive income (loss)	-$5.71M—	$0—	——	——
Total stockholders' equity	$2.11B-0.4%	$2.11B+3.9%	$2.04B+7.4%	$1.9B+2.3%
Total liabilities and stockholders' equity	$3.38B-2.0%	$3.45B+9.0%	$3.16B+2.4%	$3.09B-0.6%
Allowance for Doubtful Accounts	$924K-55.4%	$2.07M-47.6%	$3.95M-20.9%	$4.99M-19.9%
Allowance for Doubtful Accounts Receivable (Current)	$924K-55.4%	$2.07M-47.6%	$3.95M-20.9%	$4.99M-19.9%
Deferred Tax Assets and Other Non-Current Assets	$83.25M+16.3%	$71.57M+5.5%	$67.87M+30.1%	$52.18M+4.8%
Finite Lived Intangible Assets - Gross	$2B+2.3%	$1.95B+36.0%	$1.44B+2.7%	$1.4B+8.5%
Net Investment in Lease	$36.31M-15.9%	$43.19M-10.7%	$48.38M-14.3%	$56.46M-11.2%
Intangible assets — net	$1.1B-8.9%	$1.2B+44.1%	$835.95M-10.7%	$936.36M-3.8%
Other intangible assets—net	$1.1B-8.9%	$1.2B+44.1%	$835.95M-10.7%	$936.36M-3.8%
Operating lease right-of-use assets	$36.31M-15.9%	$43.19M-10.7%	$48.38M-14.3%	$56.46M-11.2%
Other non-current assets	$83.25M+16.3%	$71.57M+5.5%	$67.87M+30.1%	$52.18M+4.8%
Property, plant and equipment at cost	$40.5M+1.5%	$39.89M-15.2%	$47.03M-14.0%	$54.68M-7.3%
Operating Lease Right-of-Use Assets in Other Assets	$36.31M-15.9%	$43.19M-10.7%	$48.38M-14.3%	$56.46M-11.2%
Software and Technology Licenses, Net	$83.25M+16.3%	$71.57M+5.5%	$67.87M+30.1%	$52.18M+4.8%
Accrued Manufacturing Costs	$60.39M-12.9%	$69.33M+39.8%	$49.61M+8.2%	$45.84M-2.8%
Other Commercial Liabilities	$74.39M+18.8%	$62.63M+36.0%	$46.04M+5.4%	$43.67M-24.2%
Accrued Liabilities, Current	$74.39M+18.8%	$62.63M+36.0%	$46.04M+5.4%	$43.67M-24.2%
Compensation and benefits	$60.39M-12.9%	$69.33M+39.8%	$49.61M+8.2%	$45.84M-2.8%
Debt - Unamortized Discount (Premium) and Issuance Costs, Net	$4.5M-19.3%	$5.57M-53.2%	$11.9M-25.2%	$15.91M-17.0%
Total debt	$1B-9.7%	$1.11B+18.8%	$933.14M-6.2%	$994.49M-1.4%
Total Carrying Value of Debt	$961.88M-9.4%	$1.06B+19.7%	$886.88M-5.8%	$941.25M-0.9%
Unrecognized Tax Benefits	$27.4M+13.7%	$24.1M+25.5%	$19.2M+121%	$8.7M-25.6%
Unrecognized Tax Benefits - Impacting Effective Tax Rate	——	——	——	——
Common Stock Par Value Per Share	$0.000.0%	$0.000.0%	$0.000.0%	$0.000.0%
Common Stock Shares Issued	85M-1.8%	86.5M+0.5%	86.1M+1.6%	84.8M+1.2%
Common Stock Shares Outstanding	$5.08M-77.9%	$22.96M-18.2%	$28.07M+2.8%	$27.29M+6.1%
Convertible Preferred Stock Authorized Shares	100M0.0%	100M0.0%	100M0.0%	100M0.0%
Convertible Preferred Stock Issued Shares	0—	0—	0—	0—
Convertible Preferred Stock Outstanding Shares	0—	0—	0—	0—
Common stock; $0.001 par value; 6,000 shares authorized; 3,755 and 3,751 shares issued and outstanding as of March 31, 2026 and December 31, 2025, respectively	$8K-11.1%	$9K0.0%	$9K+12.5%	$8K0.0%
Preferred stock; $0.001 par value; 100 shares authorized; no shares issued and outstanding	$0—	$0—	$0—	$0—
Number of Exercisable Options	——	——	——	——
Number of Vested and Expected to Vest Options	——	——	——	——
Preferred Stock Par Value Per Share	$0.000.0%	$0.000.0%	$0.000.0%	$0.000.0%
Share-Based Payment Award Options Outstanding - Number	133K-64.0%	369K-49.2%	726K-28.9%	1M-17.1%
Share Repurchase Authorization Limit	——	——	——	——
Share Repurchase Program - Amount Remaining	——	——	——	——
Weighted Average Exercise Price of Outstanding Options	$47.50-1.3%	$48.13+30.4%	$36.91+2.4%	$36.06+1.2%
Weighted Average Exercise Price of Vested and Expected to Vest Options	——	——	——	——
Cumulative Cost Basis	$40.5M+1.5%	$39.89M-15.2%	$47.03M-14.0%	$54.68M-7.3%
Deferred Revenue Timing Percentage	——	——	——	——
Allowance for doubtful accounts	$924K-55.4%	$2.07M-47.6%	$3.95M-20.9%	$4.99M-19.9%
Common stock, par value (in dollars per share)	$00.0%	$00.0%	$00.0%	$00.0%
Common stock, shares authorized (in shares)	$900M0.0%	$900M0.0%	$900M0.0%	$900M0.0%
Common stock, shares issued (in shares)	$85.01M-1.8%	$86.54M+0.5%	$86.13M+1.6%	$84.76M+1.2%
Common Stock, Shares, Outstanding	$85.01M-1.8%	$86.54M+0.5%	$86.13M+1.6%	$84.76M+1.2%
Long-term debt, gross	$961.88M-9.4%	$1.06B+19.7%	$886.88M-5.8%	$941.25M-0.9%
Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net	$4.5M-19.3%	$5.57M-53.2%	$11.9M-25.2%	$15.91M-17.0%
Deferred income taxes	$93.71M+67.8%	$55.83M-18.7%	$68.67M-16.9%	$82.67M-17.2%
Finite-Lived Intangible Assets, Accumulated Amortization	$902.24M+20.3%	$750.09M+24.7%	$601.5M+29.8%	$463.53M+46.4%
Gross Carrying Amount	$2B+2.3%	$1.95B+36.0%	$1.44B+2.7%	$1.4B+8.5%
Preferred Stock, Par or Stated Value Per Share	$00.0%	$00.0%	$00.0%	$00.0%
Preferred Stock, Shares Authorized	$100M0.0%	$100M0.0%	$100M0.0%	$100M0.0%
Preferred Stock, Shares Issued	$0—	$0—	$0—	$0—
Preferred Stock, Shares Outstanding	$0—	$0—	$0—	$0—
Remaining performance obligations related to customer contracts that are unsatisfied or partially unsatisfied	$6.7M-60.8%	$17.1M+176%	$6.2M-25.3%	$8.3M-21.0%
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price	——	——	——	——
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number	$133K-64.0%	$369K-49.2%	$726K-28.9%	$1.02M-17.1%
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number	——	——	——	——
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price	$47.5-1.3%	$48.13+30.4%	$36.91+2.4%	$36.06+1.2%
Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Aggregate Intrinsic Value	——	——	——	——
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value	$5.08M-77.9%	$22.96M-18.2%	$28.07M+2.8%	$27.29M+6.1%
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price	——	——	——	——
Share-Based Compensation, Shares Authorized Under Stock Option Plans, Exercise Price Range, Upper Range Limit, Outstanding	$73.610.0%	$73.610.0%	$73.61-10.7%	$82.390.0%
Share-Based Compensation, Shares Authorized Under Stock Option Plans, Exercise Price Range, Lower Range Limit, Outstanding	$24.36+14.5%	$21.27+51.9%	$14.000.0%	$14.00+1,020%
Additional amount authorized	——	——	——	——
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Intrinsic Value	——	——	——	——
Share Repurchase Program, Authorized, Amount	——	——	——	——
Share Repurchase Program, Remaining Authorized, Amount	——	——	——	——
Unrecognized tax benefits	$27.4M+13.7%	$24.1M+25.5%	$19.2M+121%	$8.7M-25.6%
Amount that if recognized, would affect the effective tax rate or regulatory liability	——	——	——	——

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Ask your AI about HealthEquity.

Connect your AI assistant and get a quick read on the numbers, right in your chat.

Connect your AI

Claude

Questions, answered.

What are HealthEquity's total assets?: HealthEquity (HQY) holds $3.3B in total assets, down 3.2% year over year.
How much debt does HealthEquity have?: HealthEquity carries $984.7M in total debt against $2.0B of shareholders' equity, a debt-to-equity ratio of 0.48.
How much cash does HealthEquity have?: HealthEquity holds $265.4M in cash and equivalents.
Can HealthEquity cover its short-term obligations?: Its current ratio is 3.44 — current assets exceed current liabilities.
Where does HealthEquity's balance sheet data come from?: Every line is extracted from HealthEquity's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.